Northwest Biotherapeutics (NWBT)'s Dr. Marnix Bosch to Present at Brain Tumor Biotech Summit in New York
6/6/2013 7:03:53 AM
More...
|
Northwest Biotherapeutics (NWBT) Added to the MSCI Global MicroCap Index
6/4/2013 8:44:32 AM
More...
|
Northwest Biotherapeutics (NWBT) to Present Company Highlights att the Marcum MicroCap Conference in New York
5/28/2013 7:22:08 AM
More...
|
Northwest Biotherapeutics (NWBT) Exhibit at the Upcoming American Society of Clinical Oncology Meeting to Highlight its Leadership Role in Immune Therapy for Cancer
5/23/2013 7:16:29 AM
More...
|
Northwest Biotherapeutics (NWBT) Initiates Phase III DCVax®-L Brain Cancer Trial in Europe: King's College Hospital in the UK is First Site to Open
5/16/2013 10:36:54 AM
More...
|
Northwest Biotherapeutics (NWBT) Announces That Another Brain Cancer Patient From Phase I/II DCVax®-L Trials Has Surpassed Ten-Year Cancer-Free Survival
4/18/2013 9:59:47 AM
More...
|
Northwest Biotherapeutics (NWBT) Announces $10 Million Registered Direct Offering
4/18/2013 7:36:06 AM
More...
|
Northwest Biotherapeutics (NWBT)'s Phase III Trial With DCVax®-L for Brain Cancer "Adopted" as a National Priority Trial in UK
4/16/2013 10:34:46 AM
More...
|
Northwest Biotherapeutics (NWBT) 2012 Annual Report Shows Strong Progress and Enhancement of Leadership Position
4/9/2013 10:19:59 AM
More...
|
Northwest Biotherapeutics (NWBT) to Review Its Leadership Position in Immune Therapy at the 25th Annual Roth Conference
3/20/2013 8:43:23 AM
More...
|
|